Molecular Study on Physiological and Clinical Significance of Adrenomedullin
肾上腺髓质素生理和临床意义的分子研究
基本信息
- 批准号:10218204
- 负责人:
- 金额:$ 39.81万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research on Priority Areas
- 财政年份:1998
- 资助国家:日本
- 起止时间:1998 至 2002
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Adrenomedullin (AM), a potent vasorelaxing and natriuretic peptide, is thought to act as an autocrine/paracrine regulator in the vasculature as well as in renal glomeruli and tubules.In cultured bovine aortic endothelial cells, we have shown that both shear stress and oxidative stress markedly augment the synthesis and secretion of AM. Using specific anti-AM monoclonal antibody we prepared, we have demonstrated that endogenous AM produced by the endothelium inhibits PDGF-induced cell proliferation and strongly downregulates the endothelin secretion in an autocrine manner, thereby potentially protecting against vascular insults. On the other hand, AM potently stimulated the proliferation and migration of quiescent human umbilical vein endothelial cells. Using gel plug assay and laser Doppler imaging, AM stimulated vascular formation in vivo as well. We have shown that these effects of AM are mediated via the cAMP/PKA/PI3K pathway. Furthermore, we have already succeeded in the identifica … More tion and establishment of vascular progenitor cells from mouse ES cells. Using this in vitro vasculogenesis model, we found that AM receptor components, RAMP2 and CRLR, are expressed from an early stages of vascular development, suggesting that AM may play a role in vasculogenesis in vivo.In the kidney, We have shown that a significant amount of AM is produced from mesangial cells. We have demonstrated that RAMP2 and CRLR are markedly upregulated during the progression of renal fibrosis using an obstructive nephropathy model. We also showed that injured renal tissues exhibited enhanced basal and AM-stimulated cAMP production, and addition of AM in cultured renal fibroblasts inhibited proliferation and TGF-β-stimulated extracellular matrix production in a cAMP-dependent fashion.These results suggest that AM potentially exerts protective effects in the vasculature, by enhancing endothelial repair and regeneration as well as probably angiogenesis, and in the kidney, by counteracting the fibrogenic stimuli such as TGF-β. In addition, the activation of AM and its receptor system during vascular and renal injury, if any, should play a role in modulating the process of vascular and renal remodeling, against the disease progression. Less
肾上腺囊肿(AM)是一种潜在的血管长期和纳地酸肽,被认为是脉管系统中的自分泌/旁分泌调节剂,以及肾肾小球和肾小管肾小球和肾小管植物。在培养的牛主动脉主动脉细胞中,我们已经表现出了剪切应力和氧化度的分泌。使用我们制备的特定抗AM单克隆抗体,我们证明了内源性由内皮产生的内源性抑制PDGF诱导的细胞增殖,并以自分泌的方式强烈下调内皮素分泌,从而潜在地保护侵害血管感染。另一方面,AM可能刺激了静止的人脐静脉内皮细胞的增殖和迁移。使用凝胶塞分析和激光多普勒成像,还可以在体内刺激的血管形成。我们已经表明,AM的这些作用是通过CAMP/PKA/PI3K途径介导的。此外,我们已经成功地识别了……更多的和从小鼠ES细胞中建立血管祖细胞。使用这种体外血管生成模型,我们发现AM受体成分RAMP2和CRLR是从血管发育的早期阶段表达的,这表明AM可能在体内在血管生成中起作用。在肾脏中,我们表明,我们的AM大量AM是由Messianical细胞产生的。我们已经证明,使用阻塞性肾病模型,在肾纤维化进展过程中,RAMP2和CRLR显着上调。我们还表明,受伤的肾脏组织暴露了增强的基本和AM刺激的营地生产,并且在培养的肾成纤维细胞中添加AM抑制了增殖和TGF-β刺激的细胞外基质的产生。这些结果表明,通过增强内皮修复和再生以及可能的血管生成,以及通过抵消诸如TGF-β之类的纤维纤维刺激,可能会在脉管系统中发挥保护作用,并可能在肾脏中发挥保护作用。此外,在血管和肾脏损伤期间,AM及其受体系统的激活(如果有)应在调节疾病进展的血管和肾脏重塑过程中发挥作用。
项目成果
期刊论文数量(124)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Tetsuya Nagae: "Rat receptor-activity-modifying proteins (RAMPs) for adrenomedullin/CGRP receptor : Cloning and upregulation in obstructive nephropathy"Biochemical and Biophysical Research Communications. (発売予定). (2000)
Tetsuya Nagae:“肾上腺髓质素/CGRP 受体的大鼠受体活性修饰蛋白(RAMP):阻塞性肾病的克隆和上调”《生物化学和生物物理研究通讯》(待发布)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
H.Makino: "Prevention of diabetic nephropathy in rats by prostaglandin E receptor EP_1-selective antagonist"Journal of the American Society of Nephrology. 13(7). 1757-1765 (2002)
H.Makino:“前列腺素E受体EP_1选择性拮抗剂预防大鼠糖尿病肾病”美国肾脏病学会杂志。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Tokuji Tanaka: "Down-regulation of peroxisome proliferator-activated receptor γ expression by inflammatory cytokines and its reversal by thiazolidinediones"Diabetologia. 42(6). 702-710 (1999)
Tokuji Tanaka:“炎症细胞因子对过氧化物酶体增殖物激活受体 γ 表达的下调及其由噻唑烷二酮类的逆转”,Diabetologia 42(6) (1999)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Koichiro Kuwahara: "Involvement of cardiotrophin ?1 in cardiac myocyte-nonmyocyte interactions during hypertrophy of rat cardiac myocytes in vitro"Circulation. 100(15). 1116-1124 (1999)
Koichiro Kuwahara:“心肌营养素α1参与体外大鼠心肌细胞肥大过程中心肌细胞-非肌细胞相互作用”循环。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Takatoshi Saito: "Coordinate regulation of endothelin and adrenomedullin secretion by oxidative stress in endothelial cells"American Journal of Physiology. 281(3). H1364-H1371 (2001)
Takatoshi Saito:“内皮细胞氧化应激对内皮素和肾上腺髓质素分泌的协调调节”美国生理学杂志。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
NAKAO Kazuwa其他文献
NAKAO Kazuwa的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('NAKAO Kazuwa', 18)}}的其他基金
Development and analysis of model rats for diseases of endocrinology and metabolism
内分泌代谢疾病模型大鼠的建立及分析
- 批准号:
23659476 - 财政年份:2011
- 资助金额:
$ 39.81万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Physiological Function of Hormones Derived from Mesenchymal Cells and Its Failure
间充质细胞激素的生理功能及其失效
- 批准号:
21229013 - 财政年份:2009
- 资助金额:
$ 39.81万 - 项目类别:
Grant-in-Aid for Scientific Research (S)
Translational research and development of novel diagnostic/therapeutic modalities for metabolic syndrome based on adipocyte endocrinology and adiposcience
基于脂肪细胞内分泌学和脂肪科学的代谢综合征新型诊断/治疗方式的转化研究和开发
- 批准号:
16109007 - 财政年份:2004
- 资助金额:
$ 39.81万 - 项目类别:
Grant-in-Aid for Scientific Research (S)
Molecular Basis of Centrally-controled Energy Homeostasis -Focusing on Leptin Resistance-
中央控制能量稳态的分子基础 - 关注瘦素抵抗 -
- 批准号:
13307033 - 财政年份:2001
- 资助金额:
$ 39.81万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
Clinical implication of cardiovascular hormones
心血管激素的临床意义
- 批准号:
10307026 - 财政年份:1998
- 资助金额:
$ 39.81万 - 项目类别:
Grant-in-Aid for Scientific Research (A).
New Animal Models Of Leaness And Obesity by Genetic Engineering and its Application to Therapy
基因工程瘦和肥胖的新动物模型及其在治疗中的应用
- 批准号:
09557080 - 财政年份:1997
- 资助金额:
$ 39.81万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Molecular and Clinical Study of Cardiovascular Hormones
心血管激素的分子和临床研究
- 批准号:
08044272 - 财政年份:1996
- 资助金额:
$ 39.81万 - 项目类别:
Grant-in-Aid for international Scientific Research
Development of novel mouse models deficient in vasoactive substances-Clinical implication of the natriuretic peptide family and its application to gene therapy-
血管活性物质缺乏的新型小鼠模型的开发-利尿钠肽家族的临床意义及其在基因治疗中的应用-
- 批准号:
07557072 - 财政年份:1995
- 资助金额:
$ 39.81万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
Molecular Biology of Vasoactive Substances
血管活性物质的分子生物学
- 批准号:
06404037 - 财政年份:1994
- 资助金额:
$ 39.81万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
Molecular biology of vasoactive substances
血管活性物质的分子生物学
- 批准号:
06044129 - 财政年份:1994
- 资助金额:
$ 39.81万 - 项目类别:
Grant-in-Aid for international Scientific Research
相似海外基金
RAMP-altered class B GPCR hormone binding and signaling
RAMP 改变的 B 类 GPCR 激素结合和信号转导
- 批准号:
10678686 - 财政年份:2012
- 资助金额:
$ 39.81万 - 项目类别:
RAMP-altered Class B GPCR Hormone Recognition
RAMP 改变的 B 类 GPCR 激素识别
- 批准号:
8731948 - 财政年份:2012
- 资助金额:
$ 39.81万 - 项目类别:
RAMP-altered Class B GPCR Hormone Recognition
RAMP 改变的 B 类 GPCR 激素识别
- 批准号:
8914642 - 财政年份:2012
- 资助金额:
$ 39.81万 - 项目类别:
RAMP-altered class B GPCR hormone recognition
RAMP 改变的 B 类 GPCR 激素识别
- 批准号:
9384071 - 财政年份:2012
- 资助金额:
$ 39.81万 - 项目类别:
RAMP-altered class B GPCR hormone binding and signaling
RAMP 改变的 B 类 GPCR 激素结合和信号转导
- 批准号:
10798839 - 财政年份:2012
- 资助金额:
$ 39.81万 - 项目类别: